Aida Pharmaceuticals, Inc.
AIDAOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$8101
P/E Ratio—
52W High$0.0003
52W Low$0.0002
Aida Pharmaceuticals, Inc.（AIDA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AIDA · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2007-12 | 2006-12 | 2005-12 | 2004-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $29.20M | $29.64M | $24.53M | $15.64M |
| Cost of Revenue | $14.51M | $14.08M | $8.33M | $4.62M |
| Gross Profit | $14.69M | $15.56M | $16.19M | $11.02M |
| Gross Margin %(computed) | 50.31% | 52.50% | 66.03% | 70.46% |
| Operating Expenses | ||||
| R&D Expenses | $0.28M | $0.32M | $0.04M | $0.26M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $9.25M | $11.63M | $14.07M | $8.17M |
| Operating Income | $5.45M | $3.94M | $2.12M | $2.86M |
| Operating Margin %(computed) | 18.64% | 13.28% | 8.64% | 18.26% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $2.02M | $1.70M | $1.10M | $0.48M |
| Income Before Tax | $2.02M | $2.32M | $1.51M | $2.54M |
| Income Tax Expense | $0.36M | $0.17M | $0.14M | $0.15M |
| Net Income | $2.74M | $1.45M | $1.47M | $1.64M |
| Net Margin %(computed) | 9.38% | 4.91% | 5.99% | 10.45% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $0.10 | $0.06 | $0.06 | $0.07 |
| Wtd Avg Shares | 27.00M | 25.95M | 23.48M | 23.38M |
| EBITDA | $7.32M | $6.02M | $3.81M | $3.63M |
| EBITDA Margin %(computed) | 25.07% | 20.29% | 15.54% | 23.17% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Aida Pharmaceuticals, Inc.
关于Aida Pharmaceuticals, Inc.（AIDA）损益表
Aida Pharmaceuticals, Inc.（AIDA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2007财年，AIDA实现营收$0.03B，毛利润$0.01B（毛利率50.31%），净利润$0.00B（净利率9.38%）。
常见问题
AIDA · 4 问Aida Pharmaceuticals, Inc.（AIDA）2007财年营收为$0.03B，同比down1.5%。
AIDA revenueAIDA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09